Document is current
Any future updates will be listed below
-
Authors
Xu, Haiyue
Moon, Chaeho
Sahakijpijarn, Sawittree
Dao, Huy M.
Alzhrani, Riyad F.
Wang, Jie-liang
Williams, Robert O. III
Cui, Zhengrong
-
Funding
Funding for this research was provided by:
TFF Pharmaceuticals, Inc.
- License Information
-
More Information
Article History
Received: 1 October 2022
Accepted: 15 January 2023
First Online: 26 January 2023
Declarations
:
: Cui reports a relationship with TFF Pharmaceuticals, Inc. that includes equity or stocks and research funding. Williams reports a relationship with TFF Pharmaceuticals, Inc. that includes consulting or advisory, equity or stocks, and research funding. Xu and Moon report a relationship with TFF Pharmaceuticals, Inc. that includes: consulting or advisory. Financial conflict of interest management plans are available at UT Austin.
